• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症患者的基因改变

Genetic alterations in patients with primary aldosteronism.

作者信息

Takeda Y

机构信息

Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

出版信息

Hypertens Res. 2001 Sep;24(5):469-74. doi: 10.1291/hypres.24.469.

DOI:10.1291/hypres.24.469
PMID:11675938
Abstract

The syndrome of primary aldosteronism is characterized by hypertension with excessive production of aldosterone, potassium loss, and suppression of the renin-angiotensin system. The most common clinical subtypes of primary aldosteronism are aldosterone-producing adrenocortical adenoma (APA) and bilateral adrenal cortical hyperplasia (idiopathic hyperaldosteronism, or IHA). It has been reported that renin suppression and aldosterone levels are lower and hypokalemia milder in patients with IHA than in patients with APA. In the present study, we investigated the genetic analysis of aldosterone synthase gene, CYP11B2 in patients with primary aldosteronism and review the recent studies. The chimeric CYP11B1/CYP11B2 gene, which is a candidate gene for glucocorticoid-remediable hyperaldosteronism, was not found in either the DNA from aldosteronoma or in the genomic DNA from patients with APA or IHA. Mutations in the CYP21 or CYP11B1 gene were not present in patients with APA. No mutations in the coding region of the CYP11B2 gene were found in patients with IHA or APA. The level of CYP11B2 messenger RNA (mRNA) was much higher in the aldosteronoma portion than in nonadenomatous portion. The overexpression of CYP11B2 mRNA seen in the mononuclear leukocytes of patients with IHA suggests that unidentified aldosterone-stimulating factors or abnormalities of the CYP11B2 promoter region may cause the overproduction of aldosterone characteristic of IHA. The variants of the CYP11B2 gene may also contribute to dysregulation of aldosterone synthesis and lead to susceptibility to IHA.

摘要

原发性醛固酮增多症的综合征特征为高血压伴醛固酮分泌过多、钾丢失以及肾素 - 血管紧张素系统受抑制。原发性醛固酮增多症最常见的临床亚型是醛固酮分泌性肾上腺皮质腺瘤(APA)和双侧肾上腺皮质增生(特发性醛固酮增多症,或IHA)。据报道,IHA患者的肾素抑制和醛固酮水平低于APA患者,低钾血症也较轻。在本研究中,我们对原发性醛固酮增多症患者的醛固酮合成酶基因CYP11B2进行了基因分析,并回顾了近期的研究。在醛固酮瘤的DNA或APA或IHA患者的基因组DNA中均未发现嵌合型CYP11B1/CYP11B2基因,而该基因是糖皮质激素可治性醛固酮增多症的候选基因。APA患者未出现CYP21或CYP11B1基因突变。IHA或APA患者的CYP11B2基因编码区未发现突变。醛固酮瘤部分的CYP11B2信使核糖核酸(mRNA)水平远高于非腺瘤部分。IHA患者单核细胞中CYP11B2 mRNA的过表达表明,未明的醛固酮刺激因子或CYP11B2启动子区域异常可能导致IHA特有的醛固酮过度分泌。CYP11B2基因的变异也可能导致醛固酮合成失调,并导致对IHA的易感性。

相似文献

1
Genetic alterations in patients with primary aldosteronism.原发性醛固酮增多症患者的基因改变
Hypertens Res. 2001 Sep;24(5):469-74. doi: 10.1291/hypres.24.469.
2
Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.特发性醛固酮增多症患者醛固酮合酶的基因分析
J Clin Endocrinol Metab. 1999 May;84(5):1633-7. doi: 10.1210/jcem.84.5.5671.
3
Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.无嵌合型CYP11B1/CYP11B2基因的地塞米松可抑制性醛固酮增多症患者的遗传学研究
J Clin Endocrinol Metab. 2001 Oct;86(10):4805-7. doi: 10.1210/jcem.86.10.7920.
4
CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism.特发性醛固酮增多症中的CYP11B2基因多态性
Hypertension. 2000 Mar;35(3):694-8. doi: 10.1161/01.hyp.35.3.694.
5
Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.特发性醛固酮增多症的细胞和遗传病因。
Hypertension. 2018 Oct;72(4):874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086.
6
[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].基于187例原发性醛固酮增多症的回顾性分析的诊断与治疗结果
Orv Hetil. 2006 Jan 15;147(2):51-9.
7
New genetic insights in familial hyperaldosteronism.家族性醛固酮增多症的新遗传学见解。
Ann N Y Acad Sci. 2002 Sep;970:77-88. doi: 10.1111/j.1749-6632.2002.tb04414.x.
8
Disordered CYP11B2 Expression in Primary Aldosteronism.原发性醛固酮增多症中CYP11B2表达紊乱
Horm Metab Res. 2017 Dec;49(12):957-962. doi: 10.1055/s-0043-122238. Epub 2017 Dec 4.
9
A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.一种新的 CYP11B1/CYP11B2 嵌合基因表现型,其原发性醛固酮增多症的患病率较低,且基因分离模式不典型。
Hypertension. 2012 Jan;59(1):85-91. doi: 10.1161/HYPERTENSIONAHA.111.180513. Epub 2011 Nov 14.
10
Clinical Translationality of Mutation in Aldosterone Producing Adenoma.醛固酮瘤中突变的临床转化。
Int J Mol Sci. 2022 Aug 12;23(16):9042. doi: 10.3390/ijms23169042.

引用本文的文献

1
Mutagenesis of the cleavage site of (pro)renin receptor abrogates aldosterone-salt-induced hypertension and renal injury in mice.(前)肾素受体切割位点的突变可消除醛固酮-盐诱导的小鼠高血压和肾脏损伤。
Am J Physiol Renal Physiol. 2023 Jan 1;324(1):F1-F11. doi: 10.1152/ajprenal.00088.2022. Epub 2022 Oct 27.
2
COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.COX-2 非依赖性激活肾(前)肾素受体参与大鼠 DOCA-盐高血压的发生。
Am J Physiol Renal Physiol. 2020 Oct 1;319(4):F647-F653. doi: 10.1152/ajprenal.00112.2020. Epub 2020 Aug 17.
3
Primary aldosteronism, diagnosis and treatment in Japan.
原发性醛固酮增多症在日本的诊断与治疗。
Rev Endocr Metab Disord. 2011 Mar;12(1):21-5. doi: 10.1007/s11154-011-9164-6.